{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia","columns":[{"gene":"","key":"population-c1c47fd87767888f193f","label":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","mondoId":"MONDO:0017812","onsetQualifier":null,"originColumnKey":"MONDO:0017812/ORPHA:314662","originalViews":[{"key":"MONDO:0017812/ORPHA:314662","label":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","scopeLabel":"ORPHA:314662","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["008e85deac51a485506e58510836c5cf205e604a00857e5c231caa42a0c1ffd2","320e593e2beefc6e14f834b8b2e1363734cd1bc14ad6012fda7e21efd20db323","38a7c47e7da36c21b3f02a6eaa7fa381a3ce30f33a7e66a70742466a030f1614","3b396f014688b68662ecd6a9b1ea6d6e005fad3c5caedb374282280291182bdc","3e156a0c5cd5bf5c1883187863e41e9c809eba17bcbe9c121136d13acf470383","4915abefa4f2898beab9b40b1835d1b403cb8800b6162c797aa341dd1abfded4","54733729774e81f6daa48b13d6a08cf6e12d389bfda05219d3aada7c1e823491","724f40c8134b6044c4c0e0d3b7874568978644933871dcaee1f4a1077fee0d84","883105c64c3d0d8f2db18e265e300203388ef11de9dc0e121e1e666f91c33151","9f8eb36383d38e12044b74428eeee5eb4bc7c5485e93c8ad49092e563480a636","d77c55ae0f344f917657154795e2f67b388846adc3029fcfa35d91a9cd8f62d9","e4c95c6fa925d1e84b522c1c2bf88c1d94bc8bdd399d870442d3688be3685e91","f235de430fa2109e1be2278511c7f320bdd8330f11d99933a2bbcbfe9ced79ca","fb870e19e5a05b2e4881b2dff06ec0357a3d0eb2afaf2d03f03803be57a26352"],"recordQualifiers":{},"scopeLabel":"ORPHA:314662","sourceIds":["ORPHA:314662"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c1c47fd87767888f193f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0025104","HP:0002019","HP:0012725","HP:0010816","HP:0030424","HP:0000034","HP:0100774"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":14,"sourceGroups":{"orphanet":14}},"features":[{"hpoId":"HP:0025104","label":"Capillary malformation","primary":true},{"hpoId":"HP:0002019","label":"Constipation","primary":true},{"hpoId":"HP:0012725","label":"Cutaneous syndactyly","primary":true},{"hpoId":"HP:0010816","label":"Epidermal nevus","primary":true},{"hpoId":"HP:0030424","label":"Epididymal cyst","primary":true},{"hpoId":"HP:0000034","label":"Hydrocele testis","primary":true},{"hpoId":"HP:0100774","label":"Hyperostosis","primary":true},{"hpoId":"HP:0009126","label":"Increased adipose tissue","primary":false},{"hpoId":"HP:0100578","label":"Lipoatrophy","primary":false},{"hpoId":"HP:0012032","label":"Lipoma","primary":false},{"hpoId":"HP:0100559","label":"Lower limb asymmetry","primary":false},{"hpoId":"HP:0001548","label":"Overgrowth","primary":false},{"hpoId":"HP:0010442","label":"Polydactyly","primary":false},{"hpoId":"HP:0011276","label":"Vascular skin abnormality","primary":false}],"ledeHtml":"A rare PIK3CA-related overgrowth syndrome disease characterized by segmental and progressive overgrowth, predominantly involving the adipose tissue, or a mixture of adipose and fibrous tissue, with variable involvement of subcutaneous and muscular tissue, as well as skeletal overgrowth. Overgrowth severity and range is highly variable, although frequently it is asymmetric and disproportionate, it affects lower extremities more than the upper ones, and progresses in a distal to proximal patten. Congenital overgrowth is typically associated.","mondoId":"MONDO:0017812","node":{"canonicalSlug":"segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia","comparisons":[{"documentSha256":"8e294dea95fe8f2eb5eacd55be93c0088e0d49c6a528a203a2186b3c66baef1b","key":"legacy-segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia","kind":"legacy","label":"segmental progressive overgrowth syndrome with fibroadipose hyperplasia","memberIds":["MONDO:0017812"],"mondoId":"MONDO:0017812","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia.8e294dea95fe8f2eb5eacd55be93c0088e0d49c6a528a203a2186b3c66baef1b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","originalSourceId":"ORPHA:314662","paragraphs":["A rare PIK3CA-related overgrowth syndrome disease characterized by segmental and progressive overgrowth, predominantly involving the adipose tissue, or a mixture of adipose and fibrous tissue, with variable involvement of subcutaneous and muscular tissue, as well as skeletal overgrowth. Overgrowth severity and range is highly variable, although frequently it is asymmetric and disproportionate, it affects lower extremities more than the upper ones, and progresses in a distal to proximal patten. Congenital overgrowth is typically associated."],"rawAttribution":"MONDO:0017812","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:42Z","upstream":"ORPHA:314662","url":"https://rarediseases.info.nih.gov/diseases/21384"},"ownColumnKeys":["population-c1c47fd87767888f193f"],"publication":"published","relationships":[{"kind":"parent","label":"PIK3CA-related overgrowth spectrum","mondoId":"MONDO:1040002","slug":"pik3ca-related-overgrowth-spectrum"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"008e85deac51a485506e58510836c5cf205e604a00857e5c231caa42a0c1ffd2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012725","is_excluded":false,"label":"Cutaneous syndactyly","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"320e593e2beefc6e14f834b8b2e1363734cd1bc14ad6012fda7e21efd20db323","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010816","is_excluded":false,"label":"Epidermal nevus","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"38a7c47e7da36c21b3f02a6eaa7fa381a3ce30f33a7e66a70742466a030f1614","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002019","is_excluded":false,"label":"Constipation","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b396f014688b68662ecd6a9b1ea6d6e005fad3c5caedb374282280291182bdc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009126","is_excluded":false,"label":"Increased adipose tissue","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3e156a0c5cd5bf5c1883187863e41e9c809eba17bcbe9c121136d13acf470383","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010442","is_excluded":false,"label":"Polydactyly","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4915abefa4f2898beab9b40b1835d1b403cb8800b6162c797aa341dd1abfded4","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025104","is_excluded":false,"label":"Capillary malformation","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54733729774e81f6daa48b13d6a08cf6e12d389bfda05219d3aada7c1e823491","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100559","is_excluded":false,"label":"Lower limb asymmetry","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"724f40c8134b6044c4c0e0d3b7874568978644933871dcaee1f4a1077fee0d84","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030424","is_excluded":false,"label":"Epididymal cyst","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"883105c64c3d0d8f2db18e265e300203388ef11de9dc0e121e1e666f91c33151","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100774","is_excluded":false,"label":"Hyperostosis","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f8eb36383d38e12044b74428eeee5eb4bc7c5485e93c8ad49092e563480a636","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d77c55ae0f344f917657154795e2f67b388846adc3029fcfa35d91a9cd8f62d9","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001548","is_excluded":false,"label":"Overgrowth","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e4c95c6fa925d1e84b522c1c2bf88c1d94bc8bdd399d870442d3688be3685e91","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012032","is_excluded":false,"label":"Lipoma","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f235de430fa2109e1be2278511c7f320bdd8330f11d99933a2bbcbfe9ced79ca","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011276","is_excluded":false,"label":"Vascular skin abnormality","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb870e19e5a05b2e4881b2dff06ec0357a3d0eb2afaf2d03f03803be57a26352","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000034","is_excluded":false,"label":"Hydrocele testis","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21384\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017812\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:314662</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare PIK3CA-related overgrowth syndrome disease characterized by segmental and progressive overgrowth, predominantly involving the adipose tissue, or a mixture of adipose and fibrous tissue, with variable involvement of subcutaneous and muscular tissue, as well as skeletal overgrowth. Overgrowth severity and range is highly variable, although frequently it is asymmetric and disproportionate, it affects lower extremities more than the upper ones, and progresses in a distal to proximal patten. Congenital overgrowth is typically associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21384\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia","sourceDocuments":[{"name":"GARD: Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","reviewed":null,"source_release":"2026-10-21T17:03:42Z","url":"https://rarediseases.info.nih.gov/diseases/21384"},{"name":"MONDO: segmental progressive overgrowth syndrome with fibroadipose hyperplasia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017812"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"segmental progressive overgrowth syndrome with fibroadipose hyperplasia"},"schemaVersion":1}
